Cost-effectiveness of midostaurin in the treatment of newly diagnosed FLT3-mutated acute myeloid leukemia in the United States Meeting Abstract


Authors: Stein, E. M.; Xie, J.; Duchesneau, E.; Bhattacharyya, S.; Ndife, B.; Bonifacio, G.; Joseph, G. J.
Abstract Title: Cost-effectiveness of midostaurin in the treatment of newly diagnosed FLT3-mutated acute myeloid leukemia in the United States
Meeting Title: 59th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 130
Issue: Suppl. 1
Meeting Dates: 2017 Dec 9-12
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2017-12-07
Language: English
ACCESSION: WOS:000432419704295
PROVIDER: wos
DOI: 10.1182/blood.V130.Suppl_1.4703.4703
Notes: Meeting Abstract: 4703 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eytan Moshe Stein
    342 Stein